폐암 case review, 환자 처방 base, SOAP note, Pharm note 형식 발표, 주사제 배합변화 내용 포함 발표자료
- 최초 등록일
- 2016.04.27
- 최종 저작일
- 2015.08
- 26페이지/
MS 파워포인트
- 가격 2,000원
![할인쿠폰받기](/images/v4/document/ico_det_coupon.gif)
목차
1. About IV admixture
2. About Incompatibility
3. Patient’s Status
4. About Lung Cancer
5. About Chemotherapy
6. Case Review
본문내용
It is an infusion method of putting fluid into the body, usually with a syringe and hollow needle which is pierced through the skin to a sufficient depth for the material to be administered into the body
<중 략>
Incompatibility
Make solution and use it immediately as possible.
Mix minimum additions in intravenous solution.
Notify your doctors about incompatibility and make some precaution.
Keep aseptic condition, must be passed appropriate test.
Note valid data.
Use Admixture chart.
참고 자료
Alan Sandler et al, Bevacizumab in Non-Small cell lung cancer, 2006, N Engl J Med
Ettinger Ds, Wood De, et al, Non-Small Cell Lung Cancer, Version 6.2015, J Natl Compr Canc Netw
JungTae Kim, 주사제 배합변화, 1998, 병원약사회지 제2호
Cisplatin http://www.cisplatin.org/
Alimta http://www.alimta.com/
국립암정보센터
Pharmacotherphy(약물치료학) 한국임상약학회, 2015